Literature DB >> 10999472

Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands.

D J Price1, W L Jorgensen.   

Abstract

Monte Carlo/free energy perturbation (MC/FEP) simulations were performed on a series of nonpeptide ligands of the human pp60c-src SH2 domain in order to calculate relative free energies of binding for each compound and to understand the structural requirements for high affinity binding. The amido compound, exhibiting the highest experimental affinity, takes advantage of an interaction with a previously unobserved structural water.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999472     DOI: 10.1016/s0960-894x(00)00401-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials.

Authors:  Jiyao Wang; Yuqing Deng; Benoît Roux
Journal:  Biophys J       Date:  2006-07-14       Impact factor: 4.033

2.  Application of a polarizable force field to calculations of relative protein-ligand binding affinities.

Authors:  Oleg Khoruzhii; Alexander G Donchev; Nikolay Galkin; Alexei Illarionov; Mikhail Olevanov; Vladimir Ozrin; Cary Queen; Vladimir Tarasov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-24       Impact factor: 11.205

Review 3.  Computations of standard binding free energies with molecular dynamics simulations.

Authors:  Yuqing Deng; Benoît Roux
Journal:  J Phys Chem B       Date:  2009-02-26       Impact factor: 2.991

4.  Virtual high-throughput ligand screening.

Authors:  T Andrew Binkowski; Wei Jiang; Benoit Roux; Wayne F Anderson; Andrzej Joachimiak
Journal:  Methods Mol Biol       Date:  2014

5.  Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations.

Authors:  Kevin Hauser; Christopher Negron; Steven K Albanese; Soumya Ray; Thomas Steinbrecher; Robert Abel; John D Chodera; Lingle Wang
Journal:  Commun Biol       Date:  2018-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.